Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Florian Krackhardt"'
Autor:
Raphael Twerenbold, Robert Zweiker, Albrecht Schmidt, Christian Mueller, Nicole Gilgen, Georg Stachel, Ismet Oenal, Tudor C. Poerner, Bernward Lauer, Florian Krackhardt, Sylvia Otto, Alexander Wolf, Michael Kühne, Sven Möbius-Winkler, Yvonne P. Clever, Philipp Haager, Peter Ammann, Peter Rickenbacher, Ahmed Farah, Felix Mahfoud, Jochen Wöhrle, Dominik Buckert, Andreas Hoffmann, Ephraim B. Winzer, Alexandra Roettgen, Stefan Toggweiler, Frank Hölschermann, Andrea Harder-Allgoewer, Paul Erne, Dirk von Lewinski, Robert Höllriegel, Christian Butter, Hans Rickli, Andreas Wagner, Bjoern Plicht, Christian Sticherling, Rima Paliskyte, Leonhard Bruch, Frank-Peter Stephan, Lucas Joerg, Lukas Trachsel, Florian Riede, Bastian Wein, Norman Mangner, Michael J. Zellweger, Matthias Schreiber, Gregor Fahrni, Sebastian Ewen, Marc-Alexander Ohlow, Sinisa Markovic, Berthold Struck, Karsten Lenk, Marco E. G. V. Cattaneo, Stephan Schirmer, Margarete Baumgartner, Hans Roelli, Franziska Rohner, Florim Cuculi, Grit Tambor, Bruno Scheller, Raban Jeger, Axel Linke, Ella Niederl, Burkert Pieske, Dominique Nuessli, Stefan Osswald, Belal Awad, Gudrun Dannberg, Stefan Richter, Michel Noutsias, Christoph Kaiser, Steffen Bohl, Boris Keweloh, Michael Neuss, Mirko Seidel, Micha T. Maeder, Michael Boehm, Corinna Lenz, Bodo Cremers, Ioannis Kapos, Behrouz Kherad, Sabine Perl, Peter Buser, Marcus Franz, Daniel Weilenmann, Ralf Surber, Timo Jerichow, Sebastian Winkler, Olev Luha, Gregor Leibundgut
Publikováno v:
The Lancet. 396:1504-1510
In the treatment of de-novo coronary small vessel disease, drug-coated balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up to 12 months, but data beyond 1 year is sparse. We aimed to test the long-term efficac
Autor:
Berthold Struck, Alexander Wolf, Michael Kühne, Nicole Gilgen, Sebastian Winkler, Dominik Buckert, Peter Ammann, Dominique Nüssli, Lucas Joerg, Frank-Peter Stephan, Matthias Schreiber, Ralf Surber, Markus Franz, Gregor Fahrni, Peiman Jamshidi, Hans Roelli, Timo Jerichow, Sylvia Otto, Sven Möbius-Winkler, Stefan Osswald, Stefan Richter, Ahmed Farah, Felix Mahfoud, Ismet Önal, Behrouz Kherad, Andreas Wagner, Paul Erne, Robert Zweiker, Olev Luha, Florian Riede, Bernward Lauer, Frank Hölschermann, Jochen Wöhrle, Raphael Twerenbold, Albrecht Schmidt, Christian Mueller, Tudor Constantin Pörner, Peter Buser, Corinna Lenz, Ephraim B. Winzer, Bodo Cremers, Georg Stachel, Dirk von Lewinski, Alexandra Röttgen, Bruno Scheller, Raban Jeger, Leonhard Bruch, Hans Rickli, Lukas Trachsel, Andreas Hoffmann, Florian Krackhardt, Christian Butter, Sinisa Markovic, Bastian Wein, Marc-Alexander Ohlow, Stefan Toggweiler, Sebastian Ewen, Burkert Pieske, Robert Höllriegel, Yvonne P. Clever, Franziska Rohner, Christoph Kaiser, Michael Böhm, Björn Plicht, Michael Coslovsky, Karsten Lenk, Stephan Schirmer, Norman Mangner, Michael J. Zellweger, Ella Niederl, Gudrun Dannberg, Michel Noutsias, Grit Tambor, Daniel Weilenmann, Philipp Haager, Mirko Seidel, Micha T. Maeder, Gregor Leibundgut, Rima Paliskyte, Peter Rickenbacher, Axel Linke, Steffen Bohl, Michael Neuss, Christian Sticherling, Florim Cuculi, Ioannis Kapos, Sabine Perl, Belal Awad, Boris Keweloh
Publikováno v:
The Lancet. 392:849-856
Drug-coated balloons (DCB) are a novel therapeutic strategy for small native coronary artery disease. However, their safety and efficacy is poorly defined in comparison with drug-eluting stents (DES).; BASKET-SMALL 2 was a multicentre, open-label, ra
Autor:
Michel Pansieri, Matthias Waliszewski, Myung Ho Jeong, Peter Krajči, Kyu-Rock Han, Matthias Leschke, Lucie Wachowiak, Tae Hoon Ahn, Koldobika Garcia-San Roman, Florian Krackhardt, Eduard Fernandez Nofrerias, Jérôme Rischner, Bronislav Janek, Viktor Kočka, Byung-Chun Jung, Fernando Lozano, Victoria Vilalta del Olmo, Christophe Piot, Tay Mok Heang, Bruno García del Blanco, Laurent Sebagh, Milan Trenčan, Petr Tousek, Imanol Otaegui
Publikováno v:
Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Stent designs with ultrathin struts may further increase the procedural success of challenging lesion subsets. The objective of this study was to assess the safety and efficacy of ultrathin strut, polymer-free sirolimus eluting stent (PF-SES) implant
Autor:
Matthias Leschke, Fernando Lozano Ruiz-Poveda, Behrouz Kherad, Matthias Waliszewski, Liew Houng Bang, Burkert Pieske, Florian Krackhardt, Muhammad Ali Kader
Publikováno v:
Journal of Interventional Cardiology. 31:338-344
OBJECTIVES To evaluate the 9-month safety and efficacy of polymer-free sirolimus eluting drug eluting stents in septuagenarians and octogenarians. METHODS An all-comer, worldwide single armed trial (ClinicalTrials.gov Identifier NCT02629575) was cond
Autor:
Maxime Pons, André Schneider, Behrouz Kherad, Christian Sperling, Matthias Leschke, Matthias Waliszewski, Pedro Jerónimo Sousa, Florian Krackhardt, Tay Mok Heang, Mohd Ali Rosli
Publikováno v:
Catheterization and Cardiovascular Interventions. 91:1221-1228
Objective The objective of this study was to compare the safety and efficacy of a polymer-free sirolimus coated, ultrathin strut drug eluting stent (PF-SES) to its uncoated bare-metal stent (BMS) platform of identical stent architecture. Background R
Autor:
Bruno Scheller, Raban Jeger, Basket-Small Investigators, Sven Möbius-Winkler, Christian Mueller, Ahmed Farah, Daniel Weilenmann, Leonhard Bruch, Florian Krackhardt, Jochen Wöhrle, Nicole Gilgen, Frank-Peter Stephan, Christian Butter, Marc-Alexander Ohlow, Peter Rickenbacher, Norman Mangner, Christoph Kaiser, Peiman Jamshidi, Andreas Hoffmann, Robert Zweiker, Michael Coslovsky, Gregor Leibundgut
Publikováno v:
Clinical cardiology. 41(5)
The treatment of coronary small vessel disease (SVD) remains an unresolved issue. Drug-eluting stents (DES) have limited efficacy due to increased rates of instent-restenosis, mainly caused by late lumen loss. Drug-coated balloons (DCB) are a promisi
Autor:
Burkert Pieske, Fernando Lozano, Muhamad Ali Sk Abdul Kader, Liew Houng Bang, Matt Waliszewski, Markus Florian Krackhardt, Behrouz Kherad
Publikováno v:
Journal of the American College of Cardiology. 72:B345-B346
Autor:
Wilhelm Haverkamp, Matthias Rief, Florian Krackhardt, Bherous Kherad, Burkert Pieske, Florian Blaschke
Publikováno v:
North American Journal of Medical Sciences
Context: Congenital coronary anomalies, including anomalous origin, distribution, intercoronary communications, and coronary fistulae occur at a rate of approximately 1% in the general population and are the most incidental findings. Case Report: A 4
Autor:
Myung Ho Jeong, Martin Studencan, Matthias Leschke, Taehoon Ahn, Wan Azman Wan Ahmad, Martin Hudec, Andreas Utech, Markus Florian Krackhardt, Viktor Kočka, Meik Lustermann, Jiangtao Yu, Markus Schwefer, Michael Boxberger, Matt Waliszewski
Publikováno v:
Journal of the American College of Cardiology. 70:B97
The purpose of this all-comers registry was to assess the safety and efficacy of a polymer-free sirolimus coated, ultrathin strut drug eluting stent (PF-SES) with a focus on acute coronary syndrome (ACS). Elective coronary artery disease (CAD) patien
Autor:
Pedro Sousa, Markus Florian Krackhardt, Mohd Ali Rosli, André Schneider, Matt Waliszewski, Christian Sperling, Tay Mok Heang, Behrouz Kherad
Publikováno v:
Journal of the American College of Cardiology. 70:B309
Recently published randomized trials comparing BMS to DES with a focus on shortened dual-antiplatelet therapy reported incidences of stent thrombosis and bleeding complications (LEADERS FREE) in favor of drug eluting stents (DES). This study compares